Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LFNG anticorps (Middle Region)

LFNG Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN953163
  • Antigène Voir toutes LFNG Anticorps
    LFNG (LFNG O-Fucosylpeptide 3-beta-N-Acetylglucosaminyltransferase (LFNG))
    Épitope
    • 8
    • 7
    • 7
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 93-122, Middle Region
    Reactivité
    • 37
    • 8
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 29
    • 8
    Lapin
    Clonalité
    • 31
    • 6
    Polyclonal
    Conjugué
    • 20
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp LFNG est non-conjugé
    Application
    • 26
    • 25
    • 17
    • 12
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Specificité
    This antibody recognizes Human LFNG (Center).
    Purification
    Protein A column, followed by peptide affinity purification
    Immunogène
    KLH conjugated synthetic peptide between 93~122 amino acids from the Central region of human LFNG
    Isotype
    Ig Fraction
    Top Product
    Discover our top product LFNG Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS containing 0.09 % (W/V) Sodium Azide as preservative
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    LFNG (LFNG O-Fucosylpeptide 3-beta-N-Acetylglucosaminyltransferase (LFNG))
    Autre désignation
    LFNG (LFNG Produits)
    Synonymes
    anticorps SCDO3, anticorps AW061165, anticorps id:ibd2614, anticorps id:ibd5029, anticorps id:ibd5138, anticorps l-fng, anticorps wu:fc69h02, anticorps wu:fi34c01, anticorps LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, anticorps LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase S homeolog, anticorps LFNG, anticorps Lfng, anticorps lfng.S, anticorps lfng
    Sujet
    LFNG belongs to evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. This protein is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150).Synonyms: 3-N-acetylglucosaminyltransferase lunatic fringe, Beta-1, EC=2.4.1.222, LFNG, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
    Poids moléculaire
    41773 Da
    ID gène
    3955
    NCBI Accession
    NP_001035257
    Pathways
    Signalisation Notch
Vous êtes ici:
Support technique